These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23710600)

  • 1. Blood safety and availability: continuing challenges in China's blood banking system.
    Shi L; Wang JX; Stevens L; Ness P; Shan H
    Transfusion; 2014 Feb; 54(2):471-82. PubMed ID: 23710600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of blood banking and the blood supply in Afghanistan.
    Ayyoubi MT; Konstenius T; McCullough JC; Eastlund T; Clay M; Bowman R; Rahmani AM; Riley W; McCullough J
    Transfusion; 2010 Mar; 50(3):566-74. PubMed ID: 19951318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations.
    Zou S; Stramer SL; Dodd RY
    Transfus Med Rev; 2012 Apr; 26(2):119-28. PubMed ID: 21871776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward universal pathogen reduction of the blood supply (Conference Report, p. 3002).
    Marks P; Verdun N
    Transfusion; 2019 Sep; 59(9):3026-3028. PubMed ID: 31218709
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso.
    Kania D; Sangaré L; Sakandé J; Koanda A; Nébié YK; Zerbo O; Combasséré AW; Guissou IP; Rouet F
    Transfusion; 2009 Oct; 49(10):2237-40. PubMed ID: 19903285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patient-related blood donors represent a threat to the safety of the blood supply?
    Pereira A; Sanz C; Tàssies D; Ramírez B
    Haematologica; 2002 Apr; 87(4):427-33. PubMed ID: 11940488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood donation in China: sustaining efforts and challenges in achieving safety and availability.
    Yin YH; Li CQ; Liu Z
    Transfusion; 2015 Oct; 55(10):2523-30. PubMed ID: 26111254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics of apheresis platelet donors in five blood centers in China.
    Guo N; Wang J; Ness P; Yao F; Dong X; Bi X; Mei H; Li J; He W; Lu Y; Ma H; Wen X; Huang M; Liu J; Wright DJ; Shan H;
    Transfusion; 2012 Mar; 52(3):560-6. PubMed ID: 21895674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of blood components and derivatives.
    Julius C; Westphal RG
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety aspects of cord blood banking.
    Warwick RM; Barbara JA
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S40-2. PubMed ID: 9712492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donation in Chile: Replacement and volunteer donors.
    Herrera C; Martínez C; Armanet L; Cárcamo A; Boye P; Lyng C
    Biologicals; 2010 Jan; 38(1):36-8. PubMed ID: 19926303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forecasting Ontario's blood supply and demand.
    Drackley A; Newbold KB; Paez A; Heddle N
    Transfusion; 2012 Feb; 52(2):366-74. PubMed ID: 21810099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward strengthening blood transfusion services--14 countries, 2003-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(47):1273-7. PubMed ID: 19037194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District.
    Kubio C; Tierney G; Quaye T; Nabilisi JW; Ziemah C; Zagbeeb SM; Shaw S; Murphy WG
    Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood banking in China.
    Shan H; Wang JX; Ren FR; Zhang YZ; Zhao HY; Gao GJ; Ji Y; Ness PM
    Lancet; 2002 Nov; 360(9347):1770-5. PubMed ID: 12480443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.